| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $115.2M | +24.2% |
| SG&A Expense | $50.6M | +7.5% |
| Interest Expense | $1.5M | +576.4% |
| Income Tax | $0 | — |
| Net Income | -$152.6M | -12.4% |
| EPS (Basic) | -$2.08 | -2.5% |
| EPS (Diluted) | -$2.08 | -2.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.3M | -28.0% |
| Current Assets | $432.5M | -3.1% |
| Total Assets | $448.9M | -1.6% |
| Current Liabilities | $35.3M | +46.6% |
| Long-term Debt | $9.3M | +1.9% |
| Total Liabilities | $51.7M | +43.4% |
| Stockholders' Equity | $397.3M | -5.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$124.8M | -13.4% |
| Capital Expenditures | $168K | -73.2% |
| Investing Cash Flow | $15.6M | -52.3% |
| Financing Cash Flow | $94.8M | +145.8% |
| Free Cash Flow | -$125.0M | -12.9% |